Department of Preventive Medicine and Biostatistics, Division of Global Public Health, Uniformed Services University of the Health Sciences, Bethesda, MD, United States.
Kombewa Clinical Research Center, Kenya Medical Research Institute - United States Army Medical Research Directorate - Africa, Kisumu, Kenya.
Front Cell Infect Microbiol. 2022 Sep 16;12:934641. doi: 10.3389/fcimb.2022.934641. eCollection 2022.
Despite significant developments towards malaria reduction, parasite transmission in the common context of HIV-1 co-infection and treatment for one or both infections has not been fully characterized. This is particularly important given that HIV-1 and malaria chemotherapies have the potential to alter gametocyte burden and mosquito infectivity. In this study, we examined 782 blood samples collected from a longitudinal cohort of 300 volunteers with asymptomatic parasitemia seeking HIV testing or treatment in the endemic region of Kisumu, Kenya, to define the impacts of HIV-1-malaria co-infection, antiretroviral therapy (ART) plus trimethoprim-sulfamethoxazole (TS) and the antimalarials artemether/lumefantrine (AL) on gametocyte transcript prevalence and parasite transmission to the African malaria mosquito . Volunteers were assigned to three distinct HIV-1 groups: HIV-1 positive on treatment, HIV-1 positive newly diagnosed, and HIV-1 negative. Volunteers were monitored monthly over the course of six months. Using our highly sensitive digital droplet PCR (ddPCR) assay of three gametocyte specific transcript markers, we detected gametocyte transcripts in 51.1% of positive volunteers across all study groups and time points. After correcting for multiple comparisons, the factors of HIV-1 status, time, CD4+ T-cell levels and hematocrit were not predictive of gametocyte prevalence or transmission. However, among those volunteers who were newly diagnosed with HIV-1 and malaria positive by rapid diagnostic test (RDT) at enrollment, the initiation of ART/TS and AL treatment was associated with a significant reduction in gametocyte transcript prevalence in the subsequent month when compared to HIV-1 negative volunteers treated with AL. To assess gametocyte transmissibility, volunteer blood samples were used in standard membrane feeding assays (SFMA) with laboratory-reared , with evidence of transmission confirmed by at least one of 25 dissected mosquitoes per sample positive for at least one midgut oocyst. HIV-1 status, CD4+ T-cell levels and hematocrit were not significantly associated with successful transmission to Analysis of SMFA blood samples revealed that 50% of transmission-positive blood samples failed to test positive by -specific ribosomal RNA quantitative PCR (qPCR) and 35% failed to test positive for any gametocyte specific transcript marker by droplet digital (ddPCR), documenting that transmission occurred in the absence of molecular parasite/gametocyte detection. Overall, these findings highlight the complexity of HIV-1 malaria co-infection and the need to further define the unpredictable role of asymptomatic parasitemia in transmission to mosquitoes.
尽管在降低疟疾发病率方面取得了重大进展,但在 HIV-1 合并感染以及针对一种或两种感染进行治疗的常见情况下,寄生虫传播情况尚未得到充分描述。鉴于 HIV-1 和疟疾化疗药物有可能改变配子体负担和蚊子感染性,这一点尤为重要。在这项研究中,我们检查了来自肯尼亚基苏木地方性流行地区 300 名无症状寄生虫感染者的纵向队列中采集的 782 份血样,以确定 HIV-1-疟疾合并感染、抗逆转录病毒治疗 (ART) 加甲氧苄啶-磺胺甲噁唑 (TS) 和抗疟药物青蒿琥酯/甲氟喹 (AL) 对配子体转录物的流行情况和寄生虫向非洲疟蚊的传播的影响。志愿者被分配到三个不同的 HIV-1 组:正在接受治疗的 HIV-1 阳性、新诊断为 HIV-1 阳性和 HIV-1 阴性。志愿者在六个月的时间内每月接受监测。使用我们高度敏感的数字液滴 PCR (ddPCR) 检测三种配子体特异性转录物标记物,我们在所有研究组和时间点均检测到 51.1%的阳性志愿者的配子体转录物。在进行多次比较校正后,HIV-1 状态、时间、CD4+ T 细胞水平和红细胞压积等因素不能预测配子体的流行率或传播率。然而,在那些新诊断为 HIV-1 和疟疾阳性的志愿者中,与接受 AL 治疗的 HIV-1 阴性志愿者相比,ART/TS 和 AL 治疗的开始与随后一个月配子体转录物流行率的显著降低相关。为了评估配子体的传播能力,使用标准膜喂养试验 (SFMA) 对志愿者的血液样本进行了检测,用实验室饲养的蚊子进行了检测,每个样本至少有 25 只蚊子的至少一个中肠卵囊呈阳性,至少有一个检测到传播,至少有一个检测到一种配子体特异性转录物标记物。HIV-1 状态、CD4+ T 细胞水平和红细胞压积与向蚊子的成功传播无显著相关性。对 SMFA 血液样本的分析表明,50%的传播阳性血液样本未能通过 -特异性核糖体 RNA 定量 PCR(qPCR) 检测呈阳性,35%的样本未能通过滴液数字 (ddPCR) 检测呈任何配子体特异性转录物标记物阳性,这表明在没有分子寄生虫/配子体检测的情况下发生了传播。总的来说,这些发现突出了 HIV-1 疟疾合并感染的复杂性,需要进一步确定无症状寄生虫血症在向蚊子传播中的不可预测作用。